The Respiratory Evaluation Sciences Program (RESP) is a comprehensive epidemiology, health outcomes, and health economics program focused on chronic respiratory diseases (namely asthma and chronic obstructive pulmonary disease [COPD]]).
The goal of the RESP program is improving patient outcomes and the efficiency of health care delivery in respiratory diseases through evidence-informed decision making at all levels of care.
RESP has a dual focus around two themes:
Theme 1, Burden of Disease and Observational Effectiveness Research
Using population-based health administrative data and other data sources, we estimate burden of lung disease, gaps in care, and ‘real world’ effectiveness of treatments.
Theme 2, Evaluation
Using state-of-the-art mathematical decision-analytic modeling techniques, we translate the evidence on the burden of diseases and impact of interventions, programs, and policies into actionable messages on cost-effectiveness (what option provides the best value for money?).
Our research has been funded by peer-reviewed grants from multiple institutions, including